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Cirrus High-Definition Optical Coherence Tomography
Compared with Stratus Optical Coherence Tomography
in Glaucoma Diagnosis
Javier Moreno-Montan˜e´s, Natalia Olmo, Aurora Alvarez, Noelia García, and
Javier Zarranz-Ventura
PURPOSE. To compare the retinal nerve fiber layer (RNFL) eval-
uation using Cirrus optical coherence tomography (OCT) and
Stratus OCT in glaucoma diagnosis.
METHODS. One hundred thirty normal and 86 patients with
glaucoma were included in this prospective study. The signal
strengths of the OCTs were evaluated. The sensitivities and
specificities of global RNFL average thickness were compared
in the four quadrants and in each clock hour sector. Receiver
operating characteristic (ROC) curves, areas under the ROC
(AUC), and the likelihood ratio (LR) were plotted for RNFL
thickness. Agreement between the OCTs was calculated by
using the Bland-Altman method and kappa () coefficient.
RESULTS. Twenty-three percent of all cases examined with Stra-
tus OCT and 1.9% examined with Cirrus OCT had a signal
strength below 6 (P 0.01). In cases with signal strengths6,
the mean signal strength was higher with Cirrus OCT than with
Stratus OCT (P  0.01). The RNFL measurements by Cirrus
were thicker than those of Stratus OCT (P  0.05). The AUCs
were 0.829 for Stratus and 0.837 for Cirrus OCT (P  0.706)
for global RNFL average. LRs were similar in both OCTs in
global RNFL classification but varied in quadrants. The widths
of the limits of agreement varied between 42.16 and 97.79 m.
There was almost perfect agreement (  0.82) in the average
RNFL classification.
CONCLUSIONS. Cirrus OCT has better scan quality than Stratus
OCT, especially in glaucomatous eyes. In cases with good-
quality scans, the sensitivity and specificity, and AUCs were
similar. The best agreement was in the global average RNFL
classification. The widths of limits of agreements exceed the
limits of resolution of the OCTs. (Invest Ophthalmol Vis Sci.
2010;51:335–343) DOI:10.1167/iovs.08-2988
Optical coherence tomography (OCT) is an optical imagingtechnique that provides high resolution, cross-sectional,
in vivo measurements of the retinal nerve fiber layer (RNFL) in
a fashion similar to B-scan ultrasonography. Since OCT was
introduced in 1991,1 several ocular applications have been
developed. Different OCT systems have been introduced re-
cently for quantitative and qualitative analysis of the RNFL, and
use glaucoma algorithms to measure the thickness along a
3.4-mm-diameter circle centered on the optic disc.
Stratus OCT 3000 (Carl Zeiss Meditec, Dublin, CA) is a
third-generation model with approximately 7- to 8-m resolu-
tion.2 The RNFL appears graphically as a double hump, and the
system also shows the global average and averages for each
quadrant and clock hour position. Each average is classified as
normal, borderline, or abnormal based on comparison with a
normative database, with normal and glaucomatous cases dis-
tributed by age.3
New high-definition (HD) OCTs recently have become avail-
able. Spectral-domain OCT provides faster scanning than pre-
vious OCTs, allowing three-dimensional imaging of retinal tis-
sue. Carl Zeiss Meditec introduced a spectral-domain OCT
system, Cirrus, that offers faster scanning and better axial
resolution than its predecessor, Stratus. Cirrus is an HD OCT
system with an axial resolution of 6 m and a scanning speed
of up to 25,000 A-scans/s.4 The scanning area covers 6  6
mm, and the scanning depth is 2 mm.4 Because of spectral-
domain technology, Cirrus OCT provides a twofold higher
resolution than Stratus OCT generates during the same time
frame. Like Stratus, Cirrus analyzes a 3.4-mm-diameter circle
automatically centered on the optic disc inside a 6  6 map
and compares the results with those in a normal database.
The goal of the present study was to compare the RNFL
measurements and RNFL classification by using the database
between the Cirrus and Stratus OCTs in normal and glaucoma-
tous eyes. We also compared the quality of the RNFL measure-
ment between the OCTs.
METHODS
Subjects
Normal eyes and eyes with glaucoma were recruited prospectively in
the Department of Ophthalmology, Clínica Universidad de Navarra,
Pamplona, Spain. The study was approved by the institutional review
board/ethics committee. According to this committee no written in-
formed consent was needed in the glaucoma group, because this
evaluation was performed on data that are normally obtained in clinical
practice. All normal volunteers provided informed consent before
entering the study, which adhered to the Declaration of Helsinki.
Complete ophthalmic examinations of all participants were per-
formed that included slit lamp biomicroscopy, intraocular pressure
(IOP) measurement, dilated stereoscopic fundus examination, gonios-
copy, and standard automated perimetry using the 24- 2 Swedish
Interactive Threshold Algorithm (Humphrey Field Analyzer; Carl Zeiss,
Meditec). All participants were Caucasian and had a spherical equiva-
lent within 5.0 D or less and astigmatism of 3.00 D or less, a best
corrected visual acuity (VA) of 20/40 or better (0.3 logMAR), no
corneal or retinal disease, no history of amblyopia, no contraindication
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to dilation or intolerance of topical anesthetic or mydriatic agents, and
no substantial media opacity that obscured the fundus.
The glaucoma group included cases with a clinical diagnosis of
open-angle glaucoma identified by gonioscopy and visual field defects.
The IOP exceeded 21 mm Hg on at least three different days. The visual
field was classified as glaucomatous according to a glaucoma staging
system (GSS) that was a modified version of the Hodapp-Anderson-
Parrish classification.5 This classification allows for assignments of
glaucoma stage on the basis of visual field damage. The staging system
assigns patients with glaucoma to different stages of disease progres-
sion on the basis of a combination of mean defect (MD) score and one
of the following: pattern deviation probability plot score (indicating
deviation from a normalized visual field pattern); decibel plot (stages
2–4) or; for stage 1, either corrected pattern SD/pattern SD (CPSD/
PSD) or glaucoma hemifield test results. The stages are 0 (ocular
hypertension), 1 (early glaucoma), 2 (moderate glaucoma), 3 (ad-
vanced glaucoma), 4 (severe glaucoma), 5 (blindness). This visual field
damage was reproducible in at least three reliable and consecutive
visual fields performed on different days. In cases of bilateral glaucoma,
only a randomized eye was included. The normal group included
patients with an IOP of 21 mm Hg or lower, normal visual fields, and
no familial glaucoma history. This normal group included patients
consecutively recruited from hospital staff, nurses, relatives of patients,
and patients referred for a routine VA examination without ocular
diseases.
A total of 216 eyes (106 right and 110 left eyes) of 216 patients (109
men, 107 women) were enrolled. The mean age  SD was 59.57 
18.43 years. One hundred thirty eyes were normal and 86 were glau-
comatous. Mean age in the normal group was 58.22 10.85 years and,
in the glaucomatous group, 60.12  12.45 years (P  0.285).
Observation Procedures
After pupillary dilation with 1% tropicamide, OCT evaluation using
Stratus and Cirrus was performed on the same day. Before the study,
both OCTs were calibrated by the manufacturer. The OCT examina-
tions in both instruments were performed by an experienced operator
who was different from the examiner who performed the visual field
testing and was masked to the other findings. The first 30 examinations
with the Cirrus OCT were not included in the analysis and were
considered part of the learning curve.
Stratus OCT was performed first because it requires more cooper-
ation from the patient than does Cirrus OCT, as observed during the
learning curve with Cirrus OCT.
Stratus OCT Examination. The eyes were measured with the
peripapillary fast RNFL program. When the fast RNFL program is used,
the RNFL thickness is determined at 256 points around a 3.4-mm
diameter around the center of the optic disc. RNFL data were analyzed
automatically with the system software (version 4.0.1 software; Carl
Zeiss Meditec). Three scans were taken, and only the best quality scan
was included and the signal strength of the scan recorded.
Cirrus OCT Examination. Three OCT volume scans (200 
200 axial scans) centered on the optic disc were acquired for each eye,
and the scan with the best signal strength was selected. RNFL data
were evaluated automatically by Cirrus OCT system software (version
3.0 software; Carl Zeiss Meditec) and the signal strength was analyzed.
The RFNL parameters evaluated in both OCTs were the global
RNFL average (in micrometers) and RNFL thickness in four quadrants
and in 12 clock hour positions. RNFL defects in clock hours were
assessed clockwise in the right eyes and counterclockwise in the left
eyes. RNFL measurements in quadrants were evaluated in the four 90°
sectors: superior, inferior, nasal, and temporal. The software in both
OCTs automatically classified all RFNL values into three groups: within
normal limits (green), borderline (yellow), and outside normal limits
(red). The numbers of cases with signal strength below 6 were counted
for both OCTs. Only cases with signal strength of 6 or higher were
included in the sensitivity and specificity analysis and the comparison
between RNFL measurements obtained by both OCTs. A qualitative
OCT evaluation was performed considering borderline cases as posi-
tive (least specific criteria) and as negative (most specific criteria).
Agreement between the qualitative RNFL classifications using both
devices also was assessed considering three possible results: complete
agreement (same classification group), partial agreement (classified by
one analysis as borderline and by the other as either within normal
limits or outside normal limits), and no agreement.
Statistical Analysis
Data were evaluated with commercial software (SPSS, ver. 15.0.1; SPSS
Inc, Chicago, IL, and MedCalc, ver. 9.2; MedCalc Software, Mariakerke,
Belgium). The Shapiro-Wilk test was used to assess the normality of the
quantitative variables. Normally distributed variables were summarized
by using the mean and SD, and nonnormally distributed variables were
summarized by using the median and interquartile ranges (IR; percen-
tiles 25 and 75). The association between Cirrus and Stratus OCT was
tested by determining Spearman’s correlation coefficient (rs). The
quantitative variables between two independent groups (the sexes and
normal and glaucomatous groups) were compared by using the Mann-
Whitney U test nonnormally distributed variables (all but age), and
two-sample Student’s t-test was used for normally distributed variables
(age only). To compare qualitative variables between independent
groups, 2 tests were used. RNFL sensitivities and specificities were
calculated for both OCTs compared with visual field classification.
Receiver operating characteristic (ROC) curves were used to deter-
mine the discriminatory capabilities between healthy and glaucoma-
tous eyes. The areas under the ROC curves (AUC) were compared by
using the Hanley-McNeil method for paired data.6 A difference be-
tween AUCs of 0.1 was considered to be clinically relevant. Using
statistical software (Medcalc), a sample size of 57 eyes per group
(control/glaucomatous) was estimated to detect a difference in AUC
over 0.1 with a power of 95% at a significance level of 5%; for a power
of 90%, a sample of 48 was needed. The sensitivities for 85% and 95%
TABLE 1. Quality of Scans in Normal and Glaucomatous Eyes
Normal Cases Glaucoma Cases All Cases
Cases, n 130 86 216
Signal strength with Stratus OCT in all eyes* 6.34  1.01 6.10  1.02 6.26  1.1
Signal strength with Cirrus OCT in all eyes* 7.95  1.09† 7.51  0.91† 7.77  1.04†
Cases with quality 6 with Stratus OCT, n (%) 24 (15.5)‡ 25 (29.1) 49 (22.7)
Cases with quality 6 with Cirrus OCT, n (%) 3 (2.3)† 1 (1.2)† 4 (1.9)†
Cases with quality 6 with both OCTs, n (%) 2 (1.5) 1 (1.2) 3 (1.4)
Signal strength* with Stratus OCT in eyes with quality 6 6.79  0.87 6.58  0.80 6.66  0.85
Signal strength* with Cirrus OCT in eyes with quality 6 8.20  0.90†‡ 7.72  0.79† 8.02  0.89†
Better quality is indicated by higher signal strength.
* Mean  SD.
† P  0.05 compared with Stratus OCT.
‡ P  0.05 compared with glaucoma cases.
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fixed specificities were calculated. Diagnostic classification of both
OCT (outside normal limits, borderline, or within normal limits) pro-
vided by each instrument after comparison with its respective norma-
tive database was also evaluated, and likelihood ratios (LRs) were
reported. The agreement of the global RNFL values (quantitative data)
was evaluated by using the Bland-Altman method.7 The agreement of
the RNFL classification (qualitative data) between both OCTs was
assessed using the weighted kappa () coefficient.8 The strength of the
qualitative agreement was categorized according to the method of
Landis and Koch9: less than 0, no agreement; 0 to 0.20, poor; 0.21 to
0.40, low; 0.41 to 0.60, moderate; 0.61 to 0.80, substantial; and 0.81 to
1.00, almost perfect.
RESULTS
Image Quality with the OCT Instruments
Table 1 shows the quality of the RNFL measurements using
both OCTs in normal and glaucomatous eyes. The mean signal
strength was higher in Cirrus OCT than in Stratus OCT in the
normal and glaucomatous groups (P  0.01). Twenty-three
percent of cases (n 49) had a signal strength of 5 or less with
Stratus OCT and 1.9% (n  4) with Cirrus OCT (P  0.01).
Older age was related to worse signal strength with Cirrus OCT
(P  0.01), but not with Stratus OCT (P  0.052). In normal
eyes signal strength was not related to global RNFL measure-
ments obtained with Cirrus OCT (P  0.655). In eyes with
glaucoma, signal strength was not related to the global RNFL
measurements obtained by Cirrus OCT (P  0.465). Finally, in
all cases, signal strength was not related to global RNFL mea-
surements (P  0.185).
In Table 2 the MDs of the visual field and the signal strength
in the glaucoma stages are included. The signal strength de-
creased according to the increase in glaucoma stage with
Stratus OCT (P 0.031), but not with Cirrus OCT (P 0.496).
In all stages, the signal strength was higher with Cirrus OCT
than with Stratus OCT (P  0.05).
After eliminating cases with signal strength of less than 6,
we had 166 cases with both OCTs with good quality scans
(105 normal eyes, 61 glaucomatous eyes). In this group, the
mean signal strength was higher with Cirrus OCT than with
Stratus OCT in normal and glaucomatous eyes and in all eyes
(P  0.01; Table 1). In all cases, 136 (81.93%) eyes had a
higher signal strength with Cirrus than Stratus OCT; in 20
(12.04%) cases, the signal strength was the same with both
OCTs, and in 10 (6.02%) cases; the signal strength was
higher with Stratus than Cirrus OCT. The signal strength
TABLE 3. RNFL Thickness Measurements by Stratus and Cirrus OCTs
Stratus OCT Cirrus OCT rs P
Global average 78.83  20.28 84.90  18.95 0.88 0.001
Quadrant
Superior 98.68  29.82 103.40  26.00 0.83 0.001
Inferior 93.22  31.56 105.40  29.59 0.82 0.001
Temporal 57.11  15.12 59.06  13.98 0.75 0.001
Nasal 66.34  18.87 68.28  12.79 0.73 0.001
Clock hour
1 91.22  32.55 95.49  25.87 0.82 0.001
2 79.12  24.65 82.17  18.65 0.73 0.004
3 56.58  18.09 60.14  14.26 0.61 0.001
4 62.75  22.32 63.25  15.63 0.60 0.02
5 83.31  30.71 89.54  25.29 0.77 0.001
6 100.11  37.60 115.56  38.14 0.79 0.001
7 96.41  37.96 110.46  37.16 0.78 0.001
8 57.45  20.55 60.88  18.60 0.63 0.001
9 46.27  12.16 49.19  13.25 0.57 0.07
10 67.16  20.25 67.73  18.56 0.76 0.001
11 101.55  31.746 104.10  31.89 0.83 0.001
12 103.58  36.37 110.36  33.27 0.74 0.001
Data are expressed as the mean  SD. rs, Spearman’s rho.
TABLE 2. Comparison of Cirrus and Stratus OCT Parameters for the Glaucoma Stages of the GSS5
Stage 1 Stage 2 Stage 3 Stage 4 P
Eyes, n 35 21 14 16
Age, y* 70.54  10.25 66.80  14.68 65.14  11.46 72.5  7.97 0.28
MD* 3.0  1.21 7.81  2.01 14.7  1.32 26.14  2.88 0.001
Signal strength in Stratus OCT* 6.4  1.16 5.9  0.88 6.29  0.99 5.56  0.36 0.031
Signal strength in Cirrus OCT* 7.51  1.01† 7.33  0.91† 7.71  0.82† 7.56  0.81† 0.496
Cases with signal strength 6 with
Stratus OCT, n (%) 6 (17.1) 7 (33.3) 4 (28.6) 8 (50) 0.11
Cases with signal strength 6 with
Cirrus OCT, n (%) 1 (2.9) 0 0 0 0.66
Global RNFL average using Stratus
OCT (all cases)* 74.13  17.10 55.49  16.24 51.61  17.54 43.60  6.80 0.001
Global RNFL average using Cirrus
OCT (all cases)* 79.34  17.69† 64.57  12.87† 66.64  14.24† 61.18  6.02† 0.001
* Mean  SD.
† P  0.05 compared with Stratus OCT.
IOVS, January 2010, Vol. 51, No. 1 Cirrus OCT Compared with Stratus OCT in Glaucoma Diagnosis 337
difference between both OCTs was related to age (P 
0.001).
Comparison of RNFL Measurements
Table 3 shows the mean  SD of RNFL thickness with both
OCTs and the Spearman correlation coefficient. This correla-
tion coefficient was significant in the global RNFL average and
in all quadrants and clock hours evaluated, except at the 9
o’clock position (rs 0.57; P  0.07). At the 1 o’clock and 11
o’clock positions, the rs were higher than in other clock hour
sectors. The global RNFL measurements average in Cirrus OCT
was higher than with Stratus OCT in 127 (76.5%) eyes and
lower in 39 (23.5%) eyes (Fig. 1). These differences between
the OCTs were unrelated to differences in signal strength (P 
0.29), age (P  0.24), sex (P  0.94), or spherical equivalent
(P  0.64).
In Table 2 the global RNFL average is compared in both
OCTs at each stage of glaucoma. In both OCTs, the global
RNFL average decreased as the glaucoma progressed to higher
stages (P  0.05). In all stages the global RNFL average was
higher with Cirrus OCT than with Stratus OCT (P  0.05).
The difference (Cirrus OCT minus Stratus OCT) was plotted
against the average of the two measurements by using Bland-
Altman plots (Table 4). The scatterplots showed that the RNFL
thickness measurements were thicker with Cirrus OCT than
with Stratus OCT in all quadrant or hour positions. The data
distribution showed that seven (4.21%) eyes were outside the
normal limits in global average RNFL (Fig. 2). In addition,
inspection of the plots revealed a wide level of agreement in
RNFL thickness measurements (width of limits of agreement
[LoA] between 42.16 m in global average RNFL and 97.79 m
at the 12 o’clock position) obtained by the two instruments.
Sensitivity and Specificity in Glaucoma Detection
Table 5 shows the best sensitivity–specificity balance, sensitiv-
ity for 85% and 95% fixed specificities, and AUCs of RNFL
thickness for discriminating between healthy and glaucoma-
tous eyes with Stratus OCT. Table 6 shows the AUCs, sensitiv-
ity, specificity, and AUCs of RNFL thickness with Cirrus OCT.
In relation to Cirrus OCT, the best sensitivity for a fixed
specificity was the global RNFL average. In the quadrants, the
best AUC was in the superior quadrant. Regarding the clock
hour positions, all AUCs were significant except the 9 o’clock
position. The sensibility and specificity of glaucoma detection
in both OCTs did not change if there was at least one abnormal
quadrant. Thus, in eyes with at least one abnormal quadrant
the sensibility and specificity was 68.9% and 89.5% with the
Stratus OCT and 70.5% and 84.8% with the Cirrus OCT.
The AUCs were compared between both OCT in the initial
stages of glaucoma (stages 1 and 2 of GSS classification)5; the
AUC for the global RNFL average with Stratus OCT was 0.796
and with Cirrus OCT, 0.776 (P  0.907). In cases of more
advanced glaucoma (stages 3 and 4 of GSS),5 the AUCs for the
global RNFL average were 0.956 and 0.934 with Stratus OCT
and Cirrus OCT, respectively (P  0.297).
The LRs with their 95% confidence intervals (CIs) for RNFL
classification after comparison with the instrument’s normative
database are presented in Tables 7 and 8. The results for the
global RNFL average were similar with both OCT systems.
Thus, the LR (95% CI) for outside normal limits was 7.08
(3.67–13.64) for Stratus-OCT and 7.87 (3.70–16.73) for Cirrus
FIGURE 1. Global average RNFL thickness measurement comparison
between Stratus and Cirrus OCT.
TABLE 4. Bland-Altman Analysis of RNFL Thickness Measurements by Stratus and Cirrus OCTs
Mean Difference  SD
(Cirrus OCT Minus Stratus OCT)
95% LoA
Lower LoA Upper LoA Width of LoA
Average 6.06  10.75 15.01 27.15 42.16
Quadrant
Superior 4.72  15.69 26.03 35.47 61.5
Inferior 12.17  17.17 21.48 45.83 67.31
Temporal 1.94  12.16 21.89 25.78 47.67
Nasal 1.94  12.56 22.69 26.58 49.27
Clock hour
1 4.27  19.71 34.37 42.92 77.29
2 3.04  17.53 31.31 37.41 68.72
3 3.56  15.16 26.16 33.29 59.45
4 0.49  18.44 35.66 36.64 72.30
5 6.22  20.24 33.45 45.91 79.36
6 15.44  24.74 33.04 63.93 96.97
7 14.05  24.68 34.31 62.42 96.73
8 3.43  18.65 33.12 39.99 73.11
9 2.92  14.44 25.39 31.23 56.62
10 0.56  14.42 27.71 28.84 56.55
11 2.54  18.10 32.92 38.02 70.94
12 6.77  24.95 55.67 42.12 97.79
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OCT. Within-normal-limits results had an LR (95% CI) of 0.36
(0.25–0.53) for Stratus OCT and 0.37 (0.25–0.53) for Cirrus
OCT for the global RNFL average. For borderline results the
LRs were higher with Cirrus OCT for global average and in all
quadrants.
Table 9 shows the differences between the AUCs from the
OCTs in RNFL thickness. In the global average RNFL thickness,
the difference was not significant (P  0.706; Fig. 3). A com-
parison of the quadrants between the OCTs showed differ-
ences in the temporal area (P  0.003). Regarding clock hour
sectors, the differences were also significant at four clock
hours.
The RNFL classification agreement was evaluated by using
the  coefficient (Table 10). The agreement was almost perfect
in the global RNFL average classification (  0.82). The best
agreement in the quadrants was in the inferior and superior
quadrants (substantial agreement). Regarding clock hour posi-
tion, the agreement varied from 7 (substantial agreement) to 3
(slight agreement) o’clock.
DISCUSSION
OCT has much potential for diagnosing glaucoma and glauco-
matous progression.10 The level of discrimination (in microme-
ters) potentially makes OCT an objective tool for diagnosing
axonal loss. This ability is important because RNFL damage
precedes measurable visual field loss.11–13 The third-generation
Stratus OCT quantifies RNFL thickness at a resolution of 8 to 10
m.14 Stratus OCT has a published sensitivity and specificity
according to glaucoma development. Thus, DeLeo´n-Ortega et
al.15 found a sensitivity and specificity of 77.22% and 80%,
Hood et al.16 reported 78% and 98%, and Budenz et al.17
reported 89% and 92% in glaucoma with manifest visual field
defects. In a previous study, we reported sensitivity/ and spec-
ificity of 80% and 74%.18 New-generation HD OCT was de-
signed to improve glaucoma detection. Cirrus OCT is an HD
OCT system with an axial resolution of 6 m and a reproduc-
ibility of 1.6 m.4 Although recent studies have reported the
usefulness of Cirrus OCT in macular diseases,19–21 to our
knowledge, no previous studies have compared the diagnostic
accuracy of Cirrus OCT and Stratus OCT for glaucoma.
In the present study, the mean signal strength with Stra-
tus OCT was 6.1  1.02 in glaucomatous eyes, and 29.1% of
glaucomatous eyes had unreliable RNFL measurements, be-
cause the signal strength was less than 6. These results are
similar to those in other published articles.22–24 The OCT
software assigns each scan a quality indicator score known
as signal strength from 1 to 10. This score is based on a
combination of signal-to-noise ratio and the uniformity of
the signal strength within a scan, but for commercial reasons
the manufacturer does not provide further details.23,25 In
most studies, the accepted minimum signal-to-noise ratio is
6.10 Wu et al.22 suggested that although the manufacturer
recommends higher signal strengths for OCT scans, in clin-
ical practice, it is not always possible to obtain a higher
FIGURE 2. Bland-Altman plot comparing the global RNFL thickness
measurements obtained with Cirrus and Stratus OCT. Mean differ-
ence  SD: RNFL measurement Cirrus minus Stratus measurement,
6.06  10.75 m; limits of agreement, 15.01 to 27.15 m.
TABLE 5. Discrimination between Healthy and Glaucomatous Eyes with Stratus OCT
AUC (95% CI) P
Sensitivity/
Specificity (%)
Sensitivity by Specificity (%)
85%
Specificity
95%
Specificity
Global average 0.829 (0.763–0.883) 0.0001 68.9/86.7 68.81 57.38
Quadrant
Superior 0.809 (0.740–0.865) 0.0001 73.8/77.1 60.66 49.15
Inferior 0.795 (0.725–0.853) 0.0001 62.3/93.3 65.57 59.02
Temporal 0.768 (0.696–0.830) 0.0001 62.3/89.5 63.93 44.26
Nasal 0.752 (0.679–0.816) 0.0001 54.1/87.6 54.10 32.79
Clock hour
1 0.762 (0.690–0.824) 0.0001 57.4/88.6 59.02 40.98
2 0.735 (0.661–0.800) 0.0001 47.5/92.4 47.54 37.70
3 0.697 (0.621–0.766) 0.0001 67.2/62.9 37.70 19.67
4 0.709 (0.634–0.777) 0.0001 45.9/87.6 45.38 22.95
5 0.735 (0.661–0.800) 0.0001 57.4/88.6 57.38 37.70
6 0.757 (0.685–0.820) 0.0001 62.3/84.8 60.66 50.82
7 0.818 (0.751–0.873) 0.0001 72.1/81.9 65.57 55.74
8 0.799 (0.730–0.857) 0.0001 72.1/79 59.02 34.43
9 0.662 (0.585–0.733) 0.0001 37.7/90.5 39.34 33.79
10 0.757 (0.684–0.820) 0.0001 60.7/89.5 62.30 44.26
11 0.792 (0.722–0.851) 0.0001 57.4/91.4 63.93 42.62
12 0.765 (0.693–0.827) 0.0001 77/66.7 45.91 36.07
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signal in many patients. In the present study, with Cirrus
OCT, the number of cases with a signal strength 6 was
only 1.9%. In most cases, the signal strength was higher with
Cirrus than with Stratus OCT (81.93%). These results sug-
gested that Cirrus OCT takes a higher quality scan than
Stratus OCT.
The differences in the present study in signal strength
between the OCTs could result from various factors. Pupil-
lary dilation can modify the signal strength. Smith et al.23
reported a mean signal strength of 5.24 with Stratus OCT in
undilated pupils, whereas the mean dilated score was 6.09,
and the acquisition of high-quality OCT images was impos-
sible without pupillary dilation in approximately 25% of
patients.23 The Stratus OCT manufacturer suggested that
3-mm pupillary dilation is needed. However, because the
Cirrus OCT uses a line scanning ophthalmoscope (LSO) with
a 750-nm superluminescent diode as a light source, the
quality of the captured images may be better than those with
Stratus OCT, because this LSO provides clear pupil visual-
ization and fundus image focusing. Another cause of differ-
ences between the signal strength of the OCTs could be
changes in the ocular media transparency.24 However, Cir-
rus OCT has an advanced optics aid when evaluating pa-
tients with cataracts.4 Finally, another possible cause could
be that both OCTs have different methods of signal strength
analysis, and a strength of 6 may not signify the same thing
in both OCTs. Although determining the causes of low
signal strength was not a study goal, we found that, with
similar conditions of pupillary dilation or lens transparency,
Cirrus OCT has better signal strength than Stratus OCT.
The mean RNFL thickness was superior in Cirrus OCT when
compared with Stratus OCT. The reason for this difference in
systems of different OCT generations could be that in each
new OCT system the axial resolution is improved over that of
TABLE 6. Discrimination between Healthy and Glaucomatous Eyes with Cirrus OCT
AUC (95% CI) P
Sensitivity/
Specificity (%)
Sensitivity by Specificity (%)
85%
Specificity
95%
Specificity
Global average 0.837 (0.772–0.889) 0.0001 80.3/79 73.77 52.46
Quadrant
Superior 0.838 (0.774–0.891) 0.0001 68.9/91.4 70.49 50.82
Inferior 0.827 (0.761–0.881) 0.0001 60.7/95.2 68.85 60.66
Temporal 0.679 (0.602–0.749) 0.0001 60.7/75.2 42.62 22.95
Nasal 0.742 (0.668–0.807) 0.0001 55.7/89.5 57.38 18.03
Clock hour
1 0.818 (0.750–0.873) 0.0001 70.5/85.7 70.49 40.98
2 0.758 (0.685–0.821) 0.0001 68.9/74.3 50.82 22.90
3 0.603 (0.524–0.678) 0.0213 62.3/57.1 21.31 9.84
4 0.644 (0.566–0.716) 0.0009 47.5/78.1 31.15 10.48
5 0.762 (0.690–0.824) 0.0001 72.1/70.5 49.18 29.51
6 0.804 (0.735–0.861) 0.0001 59/96.2 67.21 60.06
7 0.785 (0.715–0.845) 0.0001 65.6/89.5 67.21 55.74
8 0.633 (0.555–0.707) 0.0022 55.7/72.4 32.79 13.11
9 0.584 (0.505–0.660) 0.0616 34.4/84.9 34.4 14.75
10 0.745 (0.672–0.810) 0.0001 63.9/81.9 59.03 40.98
11 0.795 (0.725–0.853) 0.0001 65.6/86.7 65.57 54.10
12 0.770 (0.698–0.831) 0.0001 68.9/79 59.02 36.53
TABLE 7. Stratus OCT RNFL Classification
Parameter Within Normal Limits Borderline Outside Normal Limits
Global average 0.36 (0.25–0.53) 1.43 (0.46–4.50) 7.08 (3.67–13.64)
Quadrant
Superior 0.52 (0.40–0.69) 1.97 (0.75–5.16) 13.77 (4.32–43.84)
Inferior 0.42 (0.28–0.62) 0.43 (0.15–1.23) 5.95 (3.29–10.75)
Temporal 0.49 (0.37–0.66) 2.75 (1.33–5.68) 30.98 (4.24–226.39)
Nasal 0.89 (0.79–1.01) 2.01 (0.71–5.70) 5.16 (0.55–48.56)
Clock hour
1 0.67 (0.53–0.83) 1.55 (0.67–3.60) 13.77 (3.26–57.87)
2 0.83 (0.72–0.95) 3.10 (1.09–8.82) Infinity (NA)
3 0.89 (0.80–1.00) 2.41 (0.79–7.26) Infinity (NA)
4 0.88 (0.76–1.02) 1.72 (0.76–3.90) 5.16 (0.55–48.56)
5 0.54 (0.41–0.70) 2.37 (1.01–5.56) 9.04 (3.25–25.10)
6 0.46 (0.32–0.65) 1.26 (0.62–2.57) 6.89 (3.20–14.81)
7 0.37 (0.25–0.53) 3.87 (1.24–12.05) 7.87 (3.70–16.73)
8 0.55 (0.42–0.71) 2.95 (1.23–7.09) 8.18 (2.92–22.93)
9 0.69 (0.57–0.85) 2.41 (1.14–5.09) 15.49 (2.01–119.35)
10 0.57 (0.45–0.73) 2.71 (1.11–6.61) 15.49 (3.72–64.50)
11 0.48 (0.35–0.65) 2.49 (1.13–5.47) 6.60 (2.84–15.30)
12 0.69 (0.58–0.84) 4.73 (1.58–14.22) 8.61 (1.95–38.00)
Data are expressed as LR (95% CI). NA, not applicable.
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the previous generation. The difference can also result from
intermachine variability. Sehi et al.26 compared RNFL thickness
readings between two Stratus OCTs and found substantial
differences between the instruments in average, superior, and
inferior RNFL thickness and central foveal thickness. The in-
termachine variability was greater than interoperator variability
for all Stratus OCT measurements. Another reason for the
differences among the quadrants or the clock hour positions
may be that there is no assurance that the scans can be
obtained at exactly the same locations around the optic nerve.
Finally, Sehi et al. suggested that unexplained sources of error
(quality of superluminescent diode beams, artifacts) can con-
tribute to measurement variability.
We assessed the diagnostic capacity of OCTs by using
sensitivities and specificities and AUC comparisons. The
sensitivity and specificity of the global average RNFL were
similar in both instruments, and the AUC comparison be-
tween them was not significant (P  0.706). Leal et al.27
compared AUCs from Stratus OCT and OCT-1 and found
significantly greater values with Stratus OCT in the global
average RNFL and in the temporal quadrant measurement
in eyes with band atrophy of the optic nerve and tempo-
ral hemianopsia. Bourne at al.28 compared AUCs from
OCT 2000 and Stratus OCT and showed that the glau-
coma discrimination of the global RNFL average was
better with Stratus OCT than with OCT 2000. In the
present study, the superior and inferior quadrants had the
highest AUCs without differences between instruments (P 
0.20). Other reports of OCT 2000 and Stratus OCT found
that the superior and inferior quadrants had the best
AUCs.17,28–30
In the present study, LRs for outside normal limits results
with both OCT systems were generally associated with large
changes from pre- to posttest probability of glaucoma. Border-
line results were associated with small to moderate effects,
whereas within-normal-limits results were associated with
small effects. These results indicate that results for each of
these tests would induce only a small change in the pretest
probability of disease. The LR, which is independent of disease
prevalence, provides an indication of how much the odds of
disease change based on a positive or negative result. An LR
over 10 or under 0.1 often indicates large changes in posttest
odds of having the disease.31 Similar to Parikh et al.,32 we did
not identify a parameter with an LR that can be used to rule out
glaucoma (LR  0.1).
The study results indicated a low agreement from a clin-
ical standpoint between the Stratus and Cirrus OCTs based
on the variations in the RNFL thickness with LoA that were
relatively wider and larger compared with the limits of
resolution of both OCTs (5–10 m). Bourne et al.28 also
found low agreement when comparing RNFL readings be-
tween OCT 2000 and Stratus OCT. However, the agreement
also was evaluated by using the  coefficient to compare the
RNFL classifications from both instruments. The  coeffi-
cient varied from 0.82 (almost perfect agreement) in the
average RNFL classification with an 87.95% of cases of com-
plete agreement to 0.15 (poor agreement) at 3 (nasal area)
o’clock. In the quadrants, the highest agreement was in the
inferior quadrant (  0.71, substantial agreement) and the
lowest in the nasal area (  0.31, poor agreement). The 
values and agreement obtained in the present study were
TABLE 8. Cirrus OCT RNFL Classification
Parameter Within Normal Limits Borderline Outside Normal Limits
Global average 0.37 (0.25–0.53) 3.87 (1.24–12.05) 7.87 (3.70–16.73)
Quadrant
Superior 0.42 (0.30–0.58) 2.87 (0.71–11.59) 7.10 (3.51–14.37)
Inferior 0.39 (0.28–0.57) 0.86 (0.22–3.32) 7.96 (3.97–15.97)
Temporal 0.73 (0.60–0.87) 17.21 (2.26–131.23) 2.46 (0.99–6.13)
Nasal 0.92 (0.83–1.01) 2.58 (0.76–8.79) Infinity (NA)
Clock hour
1 0.59 (0.47–0.75) 4.02 (1.63–9.91) 22.38 (3.0–166.90)
2 0.94 (0.87–1.03) 1.72 (0.36–8.26) Infinity (NA)
3 0.97 (0.91–1.03) 2.58 (0.44–15.02) Infinity (NA)
4 0.92 (0.83–1.03) 2.07 (0.66–6.48) 3.44 (0.32–37.18)
5 0.74 (0.62–0.88) 4.30 (1.41–13.13) 5.16 (1.45–18.35)
6 0.45 (0.33–0.60) 12.05 (1.52–95.62) 12.05 (4.44–32.72)
7 0.50 (0.38–0.68) 0.52 (0.15–1.80) 17.79 (5.67–55.74)
8 0.84 (0.71–0.99) 1.72 (0.76–3.90) 3.44 (0.89–13.27)
9 0.87 (0.76–0.99) 3.87 (1.24–12.05) 1.29 (0.30–5.58)
10 0.65 (0.52–0.81) 2.46 (0.99–6.13) 8.61 (2.59–28.54)
11 0.42 (0.3–0.59) 1.72 (0.79–3.73) 12.05 (4.44–32.72)
12 0.83 (0.72–0.95) 2.41 (0.79–7.26) Infinity (NA)
Data are expressed as LR (95% CI). NA, not applicable.
TABLE 9. Difference in AUC between Cirrus and Stratus OCTs in
RNFL Thicknesses
Difference
between AUCs 95% CI P
Global average 0.00804 0.0338 to 0.0499 0.706
Quadrant
Superior 0.0299 0.0167 to 0.0765 0.208
Inferior 0.0324 0.0178 to 0.0826 0.206
Temporal 0.0888 0.0293 to 0.148 0.003
Nasal 0.0102 0.0584 to 0.0788 0.770
Clock hour
1 0.0558 0.00431 to 0.107 0.034
2 0.0229 0.0417 to 0.0874 0.694
3 0.0945 0.0105 to 0.178 0.027
4 0.0657 0.0194 to 0.151 0.130
5 0.027 0.0313 to 0.0853 0.364
6 0.0466 0.00568 to 0.0989 0.081
7 0.0328 0.0253 to 0.0908 0.001
8 0.166 0.0932 to 0.239 0.001
9 0.0777 0.00813 to 0.163 0.076
10 0.0116 0.0477 to 0.0708 0.702
11 0.00312 0.0461 to 0.0523 0.901
12 0.00468 0.0566 to 0.0659 0.881
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similar to the agreement between the Moorfields regression
analysis (MRA) comparison of the Heidelberg retinal tomo-
graph (HRT)-3 with MRA of the HRT-2 in differentiating
glaucomatous from healthy eyes.33
The present study had limitations, the first of which was
the small number of cases with glaucoma after eliminating
cases with a signal strength below 6 with the Stratus OCT
(30% of glaucoma cases). This small number of cases may
have an influence on the AUC comparison between the
groups 1/2 and 3/4 of the GSS classification. However, it was
important to compare the sensitivity and specificity in both
OCTs using only good-quality images. Second, only three
scans were acquired with both OCTs, and if we obtained
more scans, perhaps best-quality scans could be obtained
with Stratus OCT, although patient cooperation decreases
with longer examination times. Third, the order of the OCT
examination was not randomized and always started with
Stratus OCT. Because Stratus OCT necessitates more coop-
eration from the patient, we preferred to begin with the
instrument with the lowest signal strength to obtain the best
scan with Stratus OCT. The glaucomatous eyes included in
the study have different stages of visual field damage, so the
sensitivity and specificity is different in early stages of glau-
coma than in more severe glaucoma; however, we com-
pared the AUCs in two groups (initial glaucoma and ad-
vanced glaucoma), and no differences between the two
OCTs were obtained. Finally, this study included only pa-
tients with confirmed visual field loss versus normal sub-
jects. Thus, the diagnostic accuracy estimates cannot be
completely applied to clinical practice because the diagnos-
tic tests are to be used in patients with suspected disease,
not patients with confirmed diagnosis. The diagnostic accu-
racy of both OCTs in detecting glaucoma may be overesti-
mated. Medeiros et al.34 suggested that the accuracy of
diagnostic tests in glaucoma may be largely different de-
pending on the population studied and the reference stan-
dard used to define disease. However, the goal of the
present study was to compare Stratus and Cirrus OCT in the
same patients and under similar conditions. Despite these
limitations, our results may contribute to the knowledge
about the advantages of Cirrus OCT over Stratus OCT in
glaucoma detection.
In conclusion, a comparison of the Cirrus and Stratus OCTs
showed a better signal strength with the Cirrus OCT, which
included more patients with a signal strength of 6 or greater.
The sensitivity, specificity, and AUCs when comparing glauco-
matous and normal cases were similar between the OCTs in all
glaucomatous eyes, in eyes with initial glaucoma, and in eyes
with more advanced glaucoma. The LRs were similar with both
OCTs in global RNFL classification and varied in quadrants and
clock hour sectors. The quantitative and qualitative agreements
between both OCTs were better in the quadrants than in the
clock hour positions, with the best agreement in global average
RNFL thickness. Further studies are needed to compare both
OCTs in detecting glaucoma progression.
FIGURE 3. ROC curve for global RNFL thicknesses for discriminating
between healthy and glaucomatous eyes with Stratus and Cirrus OCT.
Solid line: Stratus OCT; dashed line: Cirrus OCT. AUCs: 0.829 (95% CI,
0.763–0.883) for Stratus OCT and 0.837 (95% CI, 0.772–0.889) for
Cirrus OCT (P  0.706).
TABLE 10. Agreement between RNFL Thickness Classification by Stratus and Cirrus OCT
Complete Agreement
n (%)
Partial Agreement
n (%)
No Agreement
n (%)  Coefficient (95% CI)
Global average 146 (87.95) 16 (9.63) 4 (2.4) 0.82 (0.74–0.90)
Quadrant
Superior 135 (81.32) 21 (12.65) 10 (6.02) 0.66 (0.54–0.77)
Inferior 135 (81.32) 21 (12.65) 10 (6.02) 0.71 (0.62–0.81)
Temporal 130 (78.31) 27 (16.26) 9 (5.42) 0.49 (0.36–0.63)
Nasal 148 (89.15) 15 (9.04) 3 (1.81) 0.31 (0.10–0.52)
Clock hour
1 132 (79.52) 27 (16.26) 7 (4.22) 0.51 (0.37–0.65)
2 147 (88.55) 16 (9.63) 3 (1.81) 0.27 (0.02–0.51)
3 151 (90.96) 13 (7.83) 2 (1.20) 0.15 (0–0.38)
4 141 (84.94) 19 (11.44) 6 (3.61) 0.24 (0.05–0.42)
5 133 (80.12) 23 (13.85) 10 (6.02) 0.52 (0.38–0.65)
6 132 (79.52) 28 (16.87) 6 (3.61) 0.68 (0.57–0.78)
7 135 (81.32) 23 (13.85) 8 (4.82) 0.71 (0.61–0.80)
8 135 (81.32) 21 (12.65) 10 (6.02) 0.52 (0.37–0.67)
9 139 (83.73) 21 (12.65) 6 (3.61) 0.46 (0.30–0.62)
10 130 (78.31) 29 (17.47) 7 (4.22) 0.52 (0.38–0.66)
11 133 (80.12) 26 (15.66) 7 (4.22) 0.67 (0.56–0.77)
12 143 (86.14) 17 (10.24) 6 (3.61) 0.48 (0.29–0.67)
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